EUVIMEDEUVIMED entdecken
Crossref

Long-term visual outcomes and side effects of ruthenium plaque brachytherapy in 310 eyes with small choroidal melanoma

Beatrice Gallo, Rohan Hussain, Ranaa Al-Jamal, Hagar Khalid, Ian Stoker, Gordon Hay, Amit K Arora, Mandeep S Sagoo

British Journal of Ophthalmology · 2025

DOI: 10.1136/bjo-2023-324686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Ophthalmology, 2025. Verfasst von Beatrice Gallo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK beatricegallo.bg@gmail.com. Hauptthemen laut MEDLINE: Brachytherapy, Choroid Neoplasms, Melanoma, Ruthenium Radioisotopes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aims To report the long-term visual outcomes and side effects in patients with small choroidal melanoma (CM) undergoing ruthenium-106 (Ru-106) plaque brachytherapy.

Methods

Retrospective, interventional, consecutive series of small CM ≤2.5 mm in height and ≤16 mm in largest basal diameter treated with Ru-106 plaque with a median radiation dose of 100 Gy prescribed to tumour apical height.

Results

310 patients (160 men) with a mean (SD) age of 58.4±14.1 years met the study inclusion criteria. The median follow-up was 57.5 (range 3.4–170.5) months. The mean tumour baseline thickness was 1.9±0.4 (range 0.4–2.5) mm. The mean baseline logarithm of the minimum angle of resolution (logMAR) of best corrected visual acuity (BCVA) was 0.21±0.4 (Snellen equivalent 6/9; range −0.1 to 1.5). Mean final BCVA was ≤0.3 logMAR (Snellen equivalent 6/12) in 161 patients (54.2%), better than 1.0 logMAR (Snellen equivalent 6/60) and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyChoroid NeoplasmsMelanomaRuthenium RadioisotopesVisual AcuityHumansMaleMiddle AgedFemaleRetrospective StudiesAgedFollow-Up StudiesAdultTreatment OutcomeAged, 80 and overRadiotherapy DosageTomography, Optical Coherence

Stichwörter der Autor:innen

ChoroidImagingMaculaNeoplasiaRetina

Substanzen

Ruthenium RadioisotopesRuthenium-106

Autor:innen und Institutionen

  • Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK beatricegallo.bg@gmail.com.
  • Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Ocular Oncology Service, Helsinki University Central Hospital, Helsinki, Uusimaa, Finland.
  • Medical Retina Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Ophthalmology Department, Tanta University, Tanta, Egypt.
  • Department of Radiation Physics, Barts Health NHS Trust, London, UK.

Zitieren

APA

Gallo, B., Hussain, R., Al-Jamal, R., Khalid, H., Stoker, I., Hay, G., Arora, A. K., & Sagoo, M. S. (2025). Long-term visual outcomes and side effects of ruthenium plaque brachytherapy in 310 eyes with small choroidal melanoma. British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2023-324686

Vancouver

Gallo B, Hussain R, Al-Jamal R, Khalid H, Stoker I, Hay G, et al. Long-term visual outcomes and side effects of ruthenium plaque brachytherapy in 310 eyes with small choroidal melanoma. British Journal of Ophthalmology. 2025. doi:10.1136/bjo-2023-324686

BibTeX
@article{Gallo2025,
  author = {Gallo, Beatrice and Hussain, Rohan and Al-Jamal, Ranaa and Khalid, Hagar and Stoker, Ian and Hay, Gordon and Arora, Amit K and Sagoo, Mandeep S},
  title = {Long-term visual outcomes and side effects of ruthenium plaque brachytherapy in 310 eyes with small choroidal melanoma},
  journal = {British Journal of Ophthalmology},
  year = {2025},
  doi = {10.1136/bjo-2023-324686}
}
Kostenlos starten →